AMYRIS, Inc. (AMRS) Posts Q3 Loss of 97c/Share

AMYRIS, Inc. (NASDAQ: AMRS) reported Q3 EPS of ($0.97), $0.28 worse than the analyst estimate of ($0.69). Revenue for the quarter came in at $36.28 million versus the consensus estimate of $44.82 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04